Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]

Abstract

Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583–590. On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3 is shown in Download Article. Table 3 ADRs of TBD vs Reported by Individual Active Ingredient This error was introduced by the typesetting team during the editing process and was not picked up before publication. Read the original article

Keywords

• adverse drug reactions
• active pharmacovigilance
• surveillance
• glaucoma
• timolol/brimonidine/dorzolamide.